An economic evaluation of an augmented cognitive behavioural intervention vs. computerized cognitive training for post-stroke depressive symptoms

BMC Neurology

Volumn 15, Issue 1, 2015, Pages

  van Eeden, M ^a   Kootker, J A ^b   Evers, S M A A ^a   Heugten, C M ^a,c   Geurts, A C H ^b   van Mastrigt, G A P G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUGMENTED COGNITIVE BEHAVIOURAL THERAPY; CEREBROVASCULAR ACCIDENT; COGNITIVE THERAPY; COMPUTER ASSISTED THERAPY; COMPUTERIZED COGNITIVE TRAINING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEPRESSION; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOVEMENT THERAPY; MULTICENTER STUDY (TOPIC); OCCUPATIONAL THERAPY; PATIENT ATTITUDE; PSYCHOTHERAPY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OCCUPATIONAL THERAPY; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; STROKE;

EID: 84952655022     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-015-0522-y     Document Type: Article

References (60)

1. Jaracz K, Grabowska-Fudala B, Kozubski W. Caregiver burden after stroke: towards a structural model. Neurol Neurochir Pol. 2012;46(3):224-32.
2. World Health Organization [ http://www.who.int/topics/cerebrovascular_accident/en/ ]
3. WHO. World Health Report: Changing History. Geneva, Switzerland: World Health Organization; 2004.
4. Rasquin SM, Van De Sande P, Praamstra AJ, Van Heugten CM. Cognitive-behavioural intervention for depression after stroke: five single case studies on effects and feasibility. Neuropsychol Rehabil. 2009;19(2):208-22.
5. Aben I, Verhey F, Strik J, Lousberg R, Lodder J, Honig A. A comparative study into the 1 year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psychiatry. 2003;74(5):581-5.
6. De Wit L, Putman K, Baert I, Lincoln NB, Angst F, Beyens H, et al. Anxiety and depression in the first 6 months after stroke. A longitudinal multicentre study. Disabil Rehabil. 2008;30(24):1858-66.
7. Gainotti G, Azzoni A, Lanzillotta M, Marra C, Razzano C. Some preliminary findings concerning a new scale for the assessment of depression and related symptoms in stroke patients. Ital J Neurol Sci. 1995;16(7):439-51.
8. van Mierlo ML, van Heugten CM, Post MWM, Lindeman E, de Kort PLM, Visser-Meily JMA. A longitudinal cohort study on quality of life in stroke patients and their partners: Restore4Stroke Cohort. Int J Stroke. 2014;9(1):148-54.
9. Wilkinson PR, Wolfe CD, Warburton FG, Rudd AG, Howard RS, Ross-Russell RW, et al. A long-term follow-up of stroke patients. Stroke. 1997;28(3):507-12.
10. Post-Stroke Depression [ http://www.stroke.org/we-can-help/survivors/stroke-recovery/post-stroke-conditions/emotional/depression ]
11. Lincoln NB, Brinkmann N, Cunningham S, Dejaeger E, De Weerdt W, Jenni W, et al. Anxiety and depression after stroke: a 5 year follow-up. Disabil Rehabil. 2013;35(2):140-5.
12. Rastenyte D, Kranciukaite D. Poststroke depression and its impact on quality of life. Medicina (Kaunas). 2007;43(1):1-9.
13. Husaini B, Levine R, Sharp L, Cain V, Novotny M, Hull P, et al. Depression increases stroke hospitalization cost: an analysis of 17,010 stroke patients in 2008 by race and gender. Stroke Res Treat. 2013;2013:846732.
14. Struijs JN, van Genugten ML, Evers SM, Ament AJ, Baan CA, van den Bos GA. Future costs of stroke in the Netherlands: the impact of stroke services. Int J Technol Assess Health Care. 2006;22(4):518-24.
15. van Eeden M, van Heugten CM, Evers SM. The economic impact of stroke in The Netherlands: the euro-Restore4Stroke study. BMC Public Health. 2012;12:122.
16. Hackett ML, Anderson CS. Predictors of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(10):2296-301.
17. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008;3:CD003689.
18. Broomfield NM, Laidlaw K, Hickabottom E, Murray MF, Pendrey R, Whittick JE, et al. Post-stroke depression: the case for augmented, individually tailored cognitive behavioural therapy. Clin Psychol Psychother. 2011;18(3):202-17.
19. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008;3:CD003689.
20. Cuijpers P, Smit F, Bohlmeijer E, Hollon SD, Andersson G. Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. Br J Psychiatry. 2010;196(3):173-8.
21. Hollinghurst S, Peters TJ, Kaur S, Wiles N, Lewis G, Kessler D. Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial. Br J Psychiatry. 2010;197(4):297-304.
22. Lamb SE, Hansen Z, Lall R, Castelnuovo E, Withers EJ, Nichols V, et al. Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis. Lancet. 2010;375(9718):916-23.
23. McCrone P, Ridsdale L, Darbishire L, Seed P. Cost-effectiveness of cognitive behavioural therapy, graded exercise and usual care for patients with chronic fatigue in primary care. Psychol Med. 2004;34(6):991-9.
24. van der Gaag M, Stant AD, Wolters KJ, Buskens E, Wiersma D. Cognitive-behavioural therapy for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-effectiveness analysis. Br J Psychiatry. 2011;198(1):59-65. sup 51.
25. Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, et al. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial. Health Technol Assess. 2014;18(31):1-167. vii-viii.
26. Anson K, Ponsford J. Coping and emotional adjustment following traumatic brain injury. J Head Trauma Rehabil. 2006;21(3):248-59.
27. Anson K, Ponsford J. Evaluation of a coping skills group following traumatic brain injury. Brain Inj. 2006;20(2):167-78.
28. Bedard M, Felteau M, Mazmanian D, Fedyk K, Klein R, Richardson J, et al. Pilot evaluation of a mindfulness-based intervention to improve quality of life among individuals who sustained traumatic brain injuries. Disabil Rehabil. 2003;25(13):722-31.
29. Lincoln NB, Flannaghan T, Sutcliffe L, Rother L. Evaluation of cognitive behavioural treatment for depression after stroke: a pilot study. Clin Rehabil. 1997;11(2):114-22.
30. Nicholl CR, Lincoln NB, Muncaster K, Thomas S. Cognitions and post-stroke depression. Br J Clin Psychol. 2002;41(Pt 3):221-31.
31. Vickery CD, Sepehri A, Evans CC. Self-esteem in an acute stroke rehabilitation sample: a control group comparison. Clin Rehabil. 2008;22(2):179-87.
32. de Ridder D, Geenen R, Kuijer R, van Middendorp H. Psychological adjustment to chronic disease. Lancet. 2008;372(9634):246-55.
33. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16(2):231-50.
34. Kootker J, Fasotti L, Rasquin S, van Heugten C, Geurts A. The effectiveness of an augmented cognitive behavioural intervention for post-stroke depression with or without anxiety (PSDA): the Restore4Stroke-PSDA trial. BMC Neurol. 2012;12(1):51.
35. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70.
36. O'Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, et al. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008;65(7):963-7.
37. Meyer BC, Hemmen TM, Jackson CM, Lyden PD. Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity. Stroke. 2002;33(5):1261-6.
38. van Erp J. Relaxation exercises (ontspanningsoefeningen; bodyscan, aandacht voor uw lichaam), De Hart&Vaat groep. 2010.
39. CogniPlus [ http://www.psychologischtesten.nl/c-561271/cogniplus/ ].
40. Spikman JM, Boelen DH, Lamberts KF, Brouwer WH, Fasotti L. Effects of a multifaceted treatment program for executive dysfunction after acquired brain injury on indications of executive functioning in daily life. J Int Neuropsychol Soc. 2010;16(1):118-29.
41. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27(2):363-70.
42. Golicki D, Niewada M, Buczek J, Karlinska A, Kobayashi A, Janssen MF, et al. Validity of EQ-5D-5L in stroke. Qual Life Res. 2015;24(4):845-50.
43. Lamers LM, McDonnell J, Stalmeier PFM, Krabbe PFM, Busschbach JJV. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121-32.
44. Thorn JC, Coast J, Cohen D, Hollingworth W, Knapp M, Noble SM, et al. Resource-use measurement based on patient recall: issues and challenges for economic evaluation. Appl Health Econ Health Policy. 2013;11(3):155-61.
45. Noben CY, Evers SM, Nijhuis FJ, de Rijk AE. Quality appraisal of generic self-reported instruments measuring health-related productivity changes: a systematic review. BMC Public Health. 2014;14:115.
46. Jonsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009;10(4):357-9.
47. Oostenbrink JB, Koopmanschap M.A, Rutten F.F.H. Handleiding voor Kostenonderzoek. In. Edited by Adang EMM: Institute for Medical Technology Assessment; 2010: 126.
48. Farmacotherapeutisch Kompas: Medisch farmaceutische voorlichting [ http://www.fk.cvz.nl/ ].
49. Drug costs in the Netherlands [ http://www.medicijnkosten.nl/ ].
50. Hutubessy RC, van Tulder MW, Vondeling H, Bouter LM. Indirect costs of back pain in the Netherlands: a comparison of the human capital method with the friction cost method. Pain. 1999;80(1-2):201-7.
51. Johannesson M, Karlsson G. The friction cost method: a comment. J Health Econ. 1997;16(2):249-55. discussion 257-249.
52. (CBS) CBvdS. Indexcijfers. 2012.
53. Hendriks MRC, Al MJ, Bleijlevens MHC, van Haastregt JCM, Crebolder HFJM, van Eijk JTM, et al. Continuous versus Intermittent Data Collection of Health Care Utilization, Medical Decision Making. 2013.
54. Sinharay S, Stern HS, Russell D. The use of multiple imputation for the analysis of missing data. Psychol Methods. 2001;6(4):317-29.
55. van Mastrigt GAPG. Outcome assessment and economic evaluation of short-stay intensive care for coronary artery bypass patients. Maastricht: Maastricht University; 2009.
56. Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, et al. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Br J Psychiatry. 2006;188:574-80.
57. Puhan M, Frey M, Buchi S, Schunemann H. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2008;6(1):46.
58. Raad voor Volksgezondheid en Samenleving (RVS). Zinnige en duurzame zorg. In. Zoetermeer; 2006.
59. Kind P, Hardman G, Macran S. UK Population Norms for the EQ-5D. Centre for Health Economics: The University of York; 1999.
60. Wagner M, Melnyk P, Rindress D. Systematic review of guideline recommendations on comparator selection in health economic evaluations. Montreal, Quebec, Canada: BioMedCom Consultants Inc; 2012.